Literature DB >> 8216713

Infectious immune complexes in HIV-1-infected patients.

S A Fiscus1, J D Folds, C M van der Horst.   

Abstract

Using polyethylene glycol (PEG) precipitation we have found that most HIV-1 seropositive patients have IgG containing-circulating immune complexes (CIC). In addition these CIC sometimes contain IgA, IgM, C3, and/or HIV p24 antigen. Previous work has demonstrated that patients who have plasma viremia, CD4 cell counts less than 170/mm3, or who are symptomatic are more apt to have HIV that is precipitable with PEG. In this study we report that the infectious HIV found in the plasma of patients with plasma viremia could only be found in the 2% PEG precipitates, i.e., PEG supernatants never contained infectious HIV, although they often contained noninfectious p24 antigen. These results suggested that at least some of the infectious HIV circulating in the plasma of infected patients is in the form of immune complexes. To support this idea we also demonstrated that infectious HIV could be precipitated with antiserum raised to either immunogloblins or complement components.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8216713     DOI: 10.1089/vim.1993.6.135

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  8 in total

1.  B lymphocytes in lymph nodes and peripheral blood are important for binding immune complexes containing HIV-1.

Authors:  J J Jakubik; M Saifuddin; D M Takefman; G T Spear
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

2.  CD4-Negative cells bind human immunodeficiency virus type 1 and efficiently transfer virus to T cells.

Authors:  G G Olinger; M Saifuddin; G T Spear
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 3.  Role of complement and Fc receptors in the pathogenesis of HIV-1 infection.

Authors:  D C Montefiori
Journal:  Springer Semin Immunopathol       Date:  1997

4.  The size and composition of circulating immune complexes during HIV infection.

Authors:  L B Korolevskaya; K V Shmagel; N G Shmagel; V A Chereshnev
Journal:  Dokl Biochem Biophys       Date:  2014-08-30       Impact factor: 0.788

5.  Detection and quantification of human immunodeficiency virus type 1 p24 antigen in dried whole blood and plasma on filter paper stored under various conditions.

Authors:  Chung-Chen Li; Kristy D Seidel; Robert W Coombs; Lisa M Frenkel
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  Immune complexes that contain HIV antigens activate peripheral blood T cells.

Authors:  L B Korolevskaya; K V Shmagel; E V Saidakova; N G Shmagel; V A Chereshnev
Journal:  Dokl Biol Sci       Date:  2016-09-07

7.  Lack of longitudinal intrapatient correlation between p24 antigenemia and levels of human immunodeficiency virus (HIV) type 1 RNA in patients with chronic hiv infection during structured treatment interruptions.

Authors:  Julia G Prado; Ayumi Shintani; Margarita Bofill; Bonaventura Clotet; Lidia Ruiz; Javier Martinez-Picado
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

8.  Comparison of an assay using signal amplification of the heat-dissociated p24 antigen with the Roche Monitor human immunodeficiency virus RNA assay.

Authors:  Alvaro Pascual; Ada Cachafeiro; Michele L Funk; Susan A Fiscus
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.